Related Experiment Video
Updated: Nov 3, 2025

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
A novel substrate for arrhythmias in Chagas disease
Artur Santos-Miranda1, Julliane V Joviano-Santos1, Jaqueline O Sarmento1
1Department of Biophysics, Universidade Federal de São Paulo, São Paulo, Brazil.
Insights
The Na+/Ca2+ exchanger (NCX) contributes to heart rhythm problems in chronic Chagas disease. Blocking NCX may offer a new treatment strategy for arrhythmias in Chagas disease patients.
Area of Science:
- Cardiology
- Electrophysiology
- Molecular Cardiology
Background:
- Chagas disease (CD) is a neglected tropical disease affecting millions.
- Chronic CD often leads to heart failure and life-threatening arrhythmias.
- The cellular mechanisms underlying CD-induced arrhythmias remain incompletely understood.
Purpose of the Study:
- To investigate the role of the Na+/Ca2+ exchanger (NCX) in electrical remodeling of cardiomyocytes during chronic experimental Chagas disease.
- To assess the potential of targeting NCX as a therapeutic strategy for Chagas disease-related arrhythmias.
Main Methods:
- Experimental Chagas disease was induced in C57BL/6 mice using the Colombian strain of Trypanosoma cruzi.
- Isolated cardiomyocytes from chronically infected mice (180-200 days post-infection) were studied using whole-cell patch-clamp.
- Cellular excitability and action potential (AP) properties were measured.
- Real-time PCR was used for parasite detection.
Main Results:
- Cardiomyocytes from infected mice exhibited prolonged AP repolarization and increased after-depolarizations.
- Pause-induced spontaneous activity and diastolic transient inward currents were enhanced in chagasic cardiomyocytes.
- These abnormalities were significantly reduced by blocking NCX with Ni2+ or SEA0400.
Conclusions:
- This study identifies the Na+/Ca2+ exchanger (NCX) as a key cellular arrhythmogenic substrate in cardiomyocytes from a murine model of chronic Chagas disease.
- NCX activity contributes to electrical remodeling and arrhythmogenesis in the chronic phase of experimental CD.
- Targeting NCX represents a potential novel therapeutic approach for managing arrhythmias in Chagas disease.
Background:
Chagas disease (CD) is a neglected disease that induces heart failure and arrhythmias in approximately 30% of patients during the chronic phase of the disease. Despite major efforts to understand the cellular pathophysiology of CD there are still relevant open questions to be addressed. In the present investigation we aimed to evaluate the contribution of the Na+/Ca2+ exchanger (NCX) in the electrical remodeling of isolated cardiomyocytes from an experimental murine model of chronic CD.
Methodology/Principal Findings:
Male C57BL/6 mice were infected with Colombian strain of Trypanosoma cruzi. Experiments were conducted in isolated left ventricular cardiomyocytes from mice 180-200 days post-infection and with age-matched controls. Whole-cell patch-clamp technique was used to measure cellular excitability and Real-time PCR for parasite detection. In current-clamp experiments, we found that action potential (AP) repolarization was prolonged in cardiomyocytes from chagasic mice paced at 0.2 and 1 Hz. After-depolarizations, both subthreshold and with spontaneous APs events, were more evident in the chronic phase of experimental CD. In voltage-clamp experiments, pause-induced spontaneous activity with the presence of diastolic transient inward current was enhanced in chagasic cardiomyocytes. AP waveform disturbances and diastolic transient inward current were largely attenuated in chagasic cardiomyocytes exposed to Ni2+ or SEA0400.
Conclusions/Significance:
The present study is the first to describe NCX as a cellular arrhythmogenic substrate in chagasic cardiomyocytes. Our data suggest that NCX could be relevant to further understanding of arrhythmogenesis in the chronic phase of experimental CD and blocking NCX may be a new therapeutic strategy to treat arrhythmias in this condition.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias II: Classification of Tachyarrhythmias

